Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 12, 2009, Pages 3375-3383

  Olivo Marston, Susan E ^a,b   Yang, Ping ^c   Mechanic, Leah E ^b,f   Bowman, Elise D ^b   Pine, Sharon R ^b   Loffredo, Christopher A ^d   Alberg, Anthony J ^e   Caporaso, Neil ^b   Shields, Peter G ^d   Chanock, Stephen ^b   Wu, Yanhong ^c   Jiang, Ruoxiang ^c   Cunningham, Julie ^c   Jen, Jin ^c   Harris, Curtis C ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN 2;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INNATE IMMUNITY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TOBACCO SMOKE POLLUTION;

EID: 73349117780     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0986     Document Type: Article

References (50)

1. American Cancer Society [Internet]. Cancer Facts and Figures 2009. [cited 2009 Aug 30]. Available from: http://www.cancer.org/docroot/STT/STT-0.asp.
2. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25:561-70.
3. Brownson RC, Alavanja MC, Hock ET, Loy TS. Passive smoking and lung cancer in nonsmoking women. Am J Public Health 1992;82: 1525-30.
4. Boffetta P, Tredaniel J, Greco A. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: a meta-analysis. Environ Health Perspect 2000;108:73-82.
5. Hackshaw AK. Lung cancer and passive smoking. Stat Methods Med Res 1998;7:119-36.
6. Akiba S, Kato H, Blot WJ. Passive smoking and lung cancer among Japanese women. Cancer Res 1986;46:4804-7.
7. Jinot J, Bayard S. Respiratory health effects of passive smoking: EPA's weight-of-evidence analysis. J Clin Epidemiol 1994;47:339-49.
8. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
9. StatBite: reported secondhand smoke exposure in the home among Americans. J Natl Cancer Inst 2008;100:1278.
10. Vineis P, Airoldi L, Veglia P, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005;330:277.
11. Lee CH, Ko YC, Goggins W, et al. Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women. Int J Epidemiol 2000;29:224-31.
12. Armstrong TW, Zaleski RT, Konkel WJ, Parkerton TJ. A tiered approach to assessing children's exposure: a review of methods and data. Toxicol Lett 2002;127:111-9.
13. Bearer CF. How are children different from adults? Environ Health Perspect 1995;103 Suppl 6:7-12.
14. Neri M, Ugolini D, Bonassi S, et al. Children's exposure to environmental pollutants and biomarkers of genetic damage. II. Results of a comprehensive literature search and meta-analysis. Mutat Res 2006; 612:14-39.
15. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006;7:85-94.
16. Kaur S, Thiel S, Sarma PU, Madan T. Mannan-binding lectin in asthma and allergy. Curr Allergy Asthma Rep 2006;6:377-83.
17. Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006;143:414-19.
18. Ruskamp JM, Hoekstra MO, Rovers MM, Schilder AG, Sanders EA. Mannose-binding lectin and upper respiratory tract infections in children and adolescents: a review. Arch Otolaryngol Head Neck Surg 2006;132:482-86.
19. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003;40:423-29.
20. Schlapbach LJ, Latzin P, Regamey N, et al. Mannose-binding lectin cord blood levels and respiratory symptoms during infancy: a prospective birth cohort study. Pediatr Allergy Immunol 2009;20: 219-26.
21. Thorarinsdottir HK, Ludviksson BR, Vikingsdottir T, et al. Childhood levels of immunoglobulins and mannan-binding lectin in relation to infections and allergy. Scand J Immunol 2005;61:466-74.
22. Muller S, Keil T, Gruber C, et al. MBL2 variants in relation to common childhood infections and atopy-related phenotypes in a large German birth cohort. Pediatr Allergy Immunol 2007;18:665-70.
23. Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Plasma mannan-binding lectin levels and activity are increased in allergic patients. J Allergy Clin Immunol 2005;116:1381-3.
24. Uguz A, Berber Z, Coskun M, Halide Akbas S, Yegin O. Mannose-binding lectin levels in children with asthma. Pediatr Allergy Immunol 2005;16:231-5.
25. Baccarelli A, Hou L, Chen J, et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 2006;119:1970-5.
26. Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006;68:193-209.
27. Naito H, Ikeda A, Hasegawa K, et al. Characterization of human serum mannan-binding protein promoter. J Biochem 1999;126: 1004-12.
28. Pine SR, Mechanic LE, Ambs S, et al. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 2007;99:1401-9.
29. Bohlson SS, Fraser DA, Tenner AJ. Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 2007;44:33-43.
30. Fraser DA, Bohlson SS, Jasinskiene N, et al. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 2006;80:107-16.
31. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
32. Zheng YL, Loffredo CA, Yu Z, et al. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis 2003;24:269-74.
33. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Centers for Disease Control and Prevention. 2007.
34. Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis 2004;25:1935-44.
35. Yang P, Wentzlaff KA, Katzmann JA, et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999;8:461-65.
36. Yang P, Sun Z, Krowka MJ, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med 2008;168:1097-103.
37. SNP500 [Internet]. [cited 2009 June 25]. Available from: http:// snp500cancer.nci.nih.gov.
38. StataCorp. Stata Statistical Software: Release 9. 2005.
39. R version 2.3.1. Haplo.stats. 2006.
40. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003;40:73-84.
41. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
42. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Statistical Methodology) 1995;57:289-300.
43. Bailey SL, Ennett ST, Ringwalt CL. Potential mediators, moderators, or independent effects in the relationship between parents' former and current cigarette use and their children's cigarette use. Addict Behav 1993;18:601-21.
44. Lanese RR, Banks FR, Keller MD. Smoking behavior in a teenage population: a multivariate conceptual approach. Am J Public Health 1972; 62:807-13.
45. Gazdar AF, Thun M. Lung cancer, smoke exposure, and sex. J Clin Oncol 2007;25:469-71.
46. Saraheimo M, Forsblom C, Hansen TK, et al. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 2005;48:198-202.
47. Hogaboam CM, Takahashi K, Ezekowitz RA, Kunkel SL, Schuh JM. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J Leukoc Biol 2004;75:805-14.
48. Troelsen LN, Garred P, Madsen HO, Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum 2007;56:21-29.
49. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005;35:548-55.
50. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001;2:442-50.